CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Mar. 31, 2025	Mar. 31, 2024
Revenues	$ 0	$ 0	$ 0	$ 65,297
Operating expenses:
Research and development	369	5,220	3,840	12,617
General and administrative	2,405	4,609	10,737	19,158
Total operating expenses	2,774	9,829	14,577	31,775
(Loss) income from operations	(2,774)	(9,829)	(14,577)	33,522
Other income (expense):
Interest and dividend income	202	706	836	2,669
Gain on disposition of a non-financial asset	0	0	500	0
Other expense, net	(1)	(4)	(16)	(7)
Total other income, net	201	702	1,320	2,662
Net (loss) income	$ (2,573)	$ (9,127)	$ (13,257)	$ 36,184
Net (loss) income per share - basic and diluted:
Basic	$ (0.39)	$ (1.37)	$ (1.99)	$ 5.43
Diluted	$ (0.39)	$ (1.37)	$ (1.99)	$ 5.43
Weighted-average shares used in computing net (loss) income per share - basic and diluted:
Basic	6,663	6,663	6,663	6,663
Diluted	6,663	6,663	6,663	6,663
Revenue from customers
Revenues	$ 0	$ 0	$ 0	$ 752
Revenue from collaboration agreements
Revenues	$ 0	$ 0	$ 0	$ 64,545